US STOCK
CAH Stock Analysis
US stocks · market data · technical indicators
Cardinal Health, Inc.
CAHUS stocksQuote delayed 15 min
9/11 下午02:27 updated
$236.02
-3.98-1.66%
Open
$241.27
High
$242.12
Low
$235.67
Volume
121.59萬
CAH price history
+2.07%Open
231.24
Latest
236.02
High
248.61
Low
228.46
Average
237.00
Advertisement
AI Composite Technical Analysis
BetaFormula: fundamentals (40%) + technical indicators (30%) + market sentiment (30%)
AI Score45
Score range 0–100; a higher score indicates a stronger buy signal
Market Status
HoldCurrent Price$236.02
Target Price$224.219
Change %-1.66%
Institutional
Moderate
Foreign Ownership
Accumulating
Market Heat
Cautious
Fundamentals (US)
P/E Ratio
32.30x
ROE
--
P/B Ratio
-18.85x
Dividend Yield
0.87%
Market Insight
The score sits in neutral territory (45/100). Waiting for a clearer signal may be warranted.
This analysis is for reference only and does not constitute investment advice. Investing carries risk; educational content only.
Financial snapshot
CAH - Cardinal Health, Inc.
EPS
7.22USD
Forward EPS
14.08USD
P/E
32.30x
Forward P/E
16.57x
P/B
-18.85x
ROE
--
ROA
3.72%
Operating margin
1.33%
Profit margin
0.67%
Revenue growth
5.80%
Earnings growth
68.80%
Dividend yield
0.87%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $63.67B | $60.94B | $65.63B | $64.01B | $60.16B |
| Gross profit | $2.56B | $2.50B | $2.40B | $2.32B | $2.20B |
| Operating income | $814.00M | $842.00M | $763.00M | $754.00M | $585.00M |
| Net income | $398.00M | $399.00M | $467.00M | $450.00M | $239.00M |
| Basic EPS | 1.70 | 1.69 | 1.98 | 1.89 | 1.01 |
| Diluted EPS | 1.70 | 1.69 | 1.97 | 1.88 | 1.00 |
Estimates vs actuals
Next earnings
2026-11-05
EPS estimate
2.94
Revenue estimate
$66.67B
Last surprise
+7.41%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-11-05 | 2.94 | Not reported | — |
| 2026-08-11 | 2.42 | 2.60 | +7.41% |
| 2026-04-30 | 2.79 | 3.17 | +13.70% |
| 2026-02-05 | 2.37 | 2.63 | +11.17% |
| 2025-10-30 | 2.17 | 2.55 | +17.60% |
| 2025-08-12 | 2.03 | 2.08 | +2.36% |
| 2025-05-01 | 2.15 | 2.35 | +9.36% |
| 2025-01-30 | 1.76 | 1.93 | +9.39% |
| 2024-11-01 | 1.62 | 1.88 | +15.88% |
| 2024-08-14 | 1.73 | 1.84 | +6.27% |
| 2024-05-02 | 1.95 | 2.08 | +6.63% |
| 2024-02-01 | 1.60 | 1.82 | +14.00% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $6.5B | 0.09% |
| BlackRock Inc. | 2024-06-30 | $3B | 0.07% |
| STATE STREET CORP | 2026-06-30 | $2.8B | 0.08% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $130.7M | 0.18% |
| CITADEL ADVISORS LLC | 2026-06-30 | $46.1M | 0.01% |
| Bridgewater Associates, LP | 2026-06-30 | $31.4M | 0.13% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $332.6K | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$270.94
Target range
$235.00 – $292.00
Implied upside
14.79%
Strong buy
3
Buy
12
Hold
3
Sell
0
Strong sell
0
Dividends
Annual yield
0.87%
Frequency
Quarterly
Recent payouts
- 2026-07-01$0.5158
- 2026-04-01$0.5107
- 2026-01-02$0.5107
- 2025-10-01$0.5107
Advertisement